Literature DB >> 16560864

Chaetomin, a New Antibiotic Substance Produced by Chaetomium cochliodes: II. Isolation and Concentration.

W B Geiger1, J E Conn, S A Waksman.   

Abstract

Entities:  

Year:  1944        PMID: 16560864      PMCID: PMC374003          DOI: 10.1128/jb.48.5.531-536.1944

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


× No keyword cloud information.
  1 in total

1.  Chaetomin, a New Antibiotic Substance Produced by Chaetomium cochliodes: I. Formation and Properties.

Authors:  S A Waksman; E Bugie
Journal:  J Bacteriol       Date:  1944-11       Impact factor: 3.490

  1 in total
  6 in total

1.  Scalable total syntheses of N-linked tryptamine dimers by direct indole-aniline coupling: psychotrimine and kapakahines B and F.

Authors:  Timothy Newhouse; Chad A Lewis; Kyle J Eastman; Phil S Baran
Journal:  J Am Chem Soc       Date:  2010-05-26       Impact factor: 15.419

2.  Chemotherapy of Tuberculosis-Part II.

Authors:  P D Hart
Journal:  Br Med J       Date:  1946-12-07

3.  Oxaziridine-mediated oxyamination of indoles: an approach to 3-aminoindoles and enantiomerically enriched 3-aminopyrroloindolines.

Authors:  Tamas Benkovics; Ilia A Guzei; Tehshik P Yoon
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-22       Impact factor: 15.336

Review 4.  Natural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1).

Authors:  Dale G Nagle; Yu-Dong Zhou
Journal:  Curr Drug Targets       Date:  2006-03       Impact factor: 3.465

5.  Bioactive Indolyl Diketopiperazines from the Marine Derived Endophytic Aspergillus versicolor DY180635.

Authors:  Yi Ding; Xiaojing Zhu; Liling Hao; Mengyao Zhao; Qiang Hua; Faliang An
Journal:  Mar Drugs       Date:  2020-06-28       Impact factor: 5.118

6.  Cytotoxic and antimicrobial indole alkaloids from an endophytic fungus Chaetomium sp. SYP-F7950 of Panax notoginseng.

Authors:  Fei Peng; Shao-Yang Hou; Tian-Yuan Zhang; Ying-Ying Wu; Meng-Yue Zhang; Xi-Meng Yan; Ming-Yu Xia; Yi-Xuan Zhang
Journal:  RSC Adv       Date:  2019-09-12       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.